基因合成：技術與全球市場

全球基因合成市場預計到 2025 年價值 30 億美元，到 2026 年將成長至 34 億美元，到 2031 年底將成長至 72 億美元。

預計 2026 年至 2031 年的年複合成長率（CAGR）為 16.1%。

調查範圍

本報告概述了全球基因合成市場並分析了市場趨勢。報告包含基準年（2025年）的全球收入預估（百萬美元）以及預測期（2026年至2031年）的預測數據。市場按方法、服務、最終用戶和應用進行細分。本研究涵蓋北美、歐洲、亞太地區和世界其他地區（RoW），並重點關注各地區的主要國家。

本報告重點在於影響市場和競爭格局的關鍵促進因素、趨勢和挑戰，並探討與市場相關的新興技術。報告最後提供競爭格局分析，包括全球基因合成市場主要參與者的排名和專利分析。此外，報告也特別闢出章節介紹各公司概況，涵蓋公司概要、關鍵財務資訊、產品系列及近期發展等詳細資訊。

本報告內容

• 數據表 44 和附加表 26
• 全球基因合成技術市場分析，包括當前市場規模和未來成長潛力。
• 2025 年（基準年）市場規模估算及 2026 年至 2031 年預測。
• 按方法、應用程式和最終用戶進行詳細的市場細分。
• 分析影響市場成長的關鍵市場促進因素、阻礙因素和成長機會。
• 深入洞察基因合成技術市場的產業趨勢、新興技術和發展趨勢。
• 區域市場分析，包括北美、歐洲、亞太地區和世界其他地區。
• 競爭格局分析，包括主要公司的市佔率、排名和策略趨勢
• 領先企業和新興企業概覽（包括產品系列、財務狀況和近期產業發展動態）。涵蓋企業：Integrated DNA Technologies Inc.、Thermo Fisher Scientific Inc.、Eurofins Genomics、GenScript。

目錄

第1章：摘要整理

第2章 市場概覽

• 技術背景
• 基因設計軟體及其功能
• 表達宿主的密碼子最佳化
• 盡量減少重複序列
• 清除有害因素，例如限制區域
• 新增克隆功能和融合標籤。
• 寡核苷酸合成中片段化的定義
• 基因組裝
• 基因合成服務的工作流程
• 宏觀經濟因素分析
• PESTLE分析
• 以色列、美國和伊朗之間戰爭的影響

第3章 市場動態

• 市場促進因素
• 遺傳性疾病盛行率增加
• 基因合成技術的進步
• 政府加大基因體學的投入
• 市場限制因素
• 熟練專業人員短缺
• 倫理考量
• 市場機遇
• 對細胞和基因治療的需求日益成長
• 利用CRISPR技術拓展基因編輯的應用範圍

第4章 監管情勢

• 美國
• 歐洲
• 亞太地區
• 世界其他地區

第5章：新興科技與趨勢

• 介紹
• 利用微陣列進行DNA合成
• 酶促DNA合成（EDS）
• 利用連接酶進行基因合成
• 機器學習和人工智慧
• 專利趨勢
• 概述
• 按年份統計的專利數量
• 專利（按文件類型）
• 近期與基因合成相關的專利

第6章 市場區隔分析

• 細分市場
• 市場趨勢：依方法
• 固相合成
• 基於晶片的合成
• 利用PCR進行酶合成
• 市場趨勢：依服務分類
• 抗體DNA合成
• 病毒DNA的合成
• 其他
• 市場趨勢：按應用領域分類
• 基因和細胞療法的發展
• 疫苗研發
• 疾病診斷
• 其他
• 市場趨勢：依最終用戶分類
• 生物技術和製藥公司
• 學術和政府附屬研究機構
• 受託研究機構
• 按地區分類
• 市場趨勢：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區

第7章 競爭情勢

• Integrated DNA Technologies
• Thermo Fisher Scientific
• Eurofins Genomics
• GenScript
• Twist Bioscience
• 戰略分析
• 協議、合作與夥伴關係
• 產品發布
• 其他策略發展

第8章附錄

• 調查方法
• 簡稱
• 參考
• 公司簡介
• ANSA BIOTECHNOLOGIES
• AZENTA US INC.
• CREATIVE BIOGENE
• DNA TWOPOINTO INC
• EUROFINS GENOMICS LLC
• EVONETIX
• GENSCRIPT
• INTEGRATED DNA TECHNOLOGIES INC.
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB
• SYNBIO TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• TRENZYME GMBH
• TWIST BIOSCIENCE

The global market for gene synthesis was valued at $3 billion in 2025 and is estimated to increase from $3.4 billion in 2026 to reach $7.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 16.1% from 2026 to 2031.

Report Scope

The report provides an overview of the global gene synthesis market and analyzes market trends. The report includes global revenue ($ millions) for the base year (2025) and estimated data for the forecast period (2026 through 2031). The market is segmented by method, service type, end user, and application. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World (RoW), with a focus on major countries in each region.

The report focuses on the key drivers, trends, and challenges shaping the market and competitive landscape. It also discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, including rankings of key companies in the global gene synthesis market and patent analysis. It also features a dedicated section of company profiles covering details, such as overview, key financials, product portfolio, and recent developments.

Report Includes

• 44 data tables and 26 additional tables
• Analysis of the global gene synthesis technologies market, including current market size and future growth potential
• Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
• Detailed segmentation of the market by method, application and end user
• Analysis of key market drivers, restraints, and opportunities influencing market growth
• Insights into industry trends, emerging technologies and developments in gene synthesis technologies market
• Analysis of regional markets, including North America, Europe, Asia-Pacific, Rest of the World
• Competitive landscape analysis, including market share, ranking and strategic developments of key players
• Profiles of leading and emerging companies, including their product portfolios, financials, and recent developments within the industry, Integrated DNA Technologies Inc., Thermo Fisher Scientific Inc., Eurofins Genomics, and GenScript

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Technology Background
• Gene Design Software and Features
• Codon Optimization for Expression Organism
• Minimizing Repetitive Sequences
• Removing Toxic Elements Such as Restriction Sites
• Adding Cloning Features and Fusion Tags
• Defining Oligonucleotide Synthesis Fragmentation
• Gene Assembly
• Workflow of Gene Synthesis Services
• Macro-economic Factors Analysis
• PESTEL Analysis
• Impact of the Israel-U.S.-Iran war

Chapter 3 Market Dynamics

• Market Drivers
• Increasing Prevalence of Genetic Disorders
• Developments in Gene Synthesis Techniques
• Increasing Government Funding for Genomics
• Market Restraints
• Lack of Skilled Professionals
• Ethical Considerations
• Market Opportunities
• Rising Demand for Cell and Gene Therapy
• Expansion of CRISPR-Based Gene-Editing Applications

Chapter 4 Regulatory Landscape

• U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Technologies and Developments

• Introduction
• Microarray-Based DNA Synthesis
• Enzymatic DNA Synthesis (EDS)
• Ligase-Based Gene Synthesis
• Machine Learning and Artificial Intelligence
• Patent Landscape
• Overview
• Patents, by Year
• Patents, by Document Type
• Recent Patents Relating to Gene Synthesis

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Method
• Key Takeaways
• Solid-Phase Synthesis
• Chip-Based Synthesis
• PCR-Based Enzyme Synthesis
• Market Breakdown by Services
• Key Takeaways
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Others
• Market Breakdown by Application
• Key Takeaways
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Others
• Market Breakdown by End User
• Key Takeaways
• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Contract Research Organizations
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Integrated DNA Technologies
• Thermo Fisher Scientific
• Eurofins Genomics
• GenScript
• Twist Bioscience
• Strategic Analysis
• Agreement, Collaboration and Partnership
• Product Launch
• Other Strategic Developments

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• ANSA BIOTECHNOLOGIES
• AZENTA US INC.
• CREATIVE BIOGENE
• DNA TWOPOINTO INC
• EUROFINS GENOMICS LLC
• EVONETIX
• GENSCRIPT
• INTEGRATED DNA TECHNOLOGIES INC.
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB
• SYNBIO TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• TRENZYME GMBH
• TWIST BIOSCIENCE

List of Tables

• Summary Table : Global Market for Gene Synthesis, by Region, Through 2031
• Table 1 : List of Patents Filed in Gene Synthesis Market, 2024-2025
• Table 2 : Global Market for Gene Synthesis, by Method, Through 2031
• Table 3 : Global Gene Synthesis Market for Solid-Phase Synthesis, by Region, Through 2031
• Table 4 : Global Gene Synthesis Market for Chip-Based Synthesis, by Region, Through 2031
• Table 5 : Global Gene Synthesis Market for PCR-Based Enzyme Synthesis, by Region, Through 2031
• Table 6 : Global Market for Gene Synthesis, by Services, Through 2031
• Table 7 : Global Gene Synthesis Market for Antibody DNA Synthesis, by Region, Through 2031
• Table 8 : Global Gene Synthesis Market for Viral DNA Synthesis, by Region, Through 2031
• Table 9 : Global Gene Synthesis Market for Other Services, by Region, Through 2031
• Table 10 : Global Market for Gene Synthesis, by Application, Through 2031
• Table 11 : Global Gene Synthesis Market for Gene and Cell Therapy Development, by Region, Through 2031
• Table 12 : Global Gene Synthesis Market for Vaccine Development, by Region, Through 2031
• Table 13 : Global Gene Synthesis Market for Disease Diagnosis, by Region, Through 2031
• Table 14 : Global Gene Synthesis Market for Other Applications, by Region, Through 2031
• Table 15 : Global Market for Gene Synthesis, by End User, Through 2031
• Table 16 : Global Gene Synthesis Market for Biotechnology and Pharmaceutical Companies, by Region, Through 2031
• Table 17 : Global Gene Synthesis Market for Academic and Government Research Institutes, by Region, Through 2031
• Table 18 : Global Gene Synthesis Market for Contract Research Organizations, by Region, Through 2029
• Table 19 : Global Market for Gene Synthesis, by Region, Through 2031
• Table 20 : North American Market for Gene Synthesis, by Method, Through 2031
• Table 21 : North American Market for Gene Synthesis, by Services, Through 2031
• Table 22 : North American Market for Gene Synthesis, by Application, Through 2031
• Table 23 : North American Market for Gene Synthesis, by End User, Through 2031
• Table 24 : North American Market for Gene Synthesis, by Country, Through 2031
• Table 25 : European Market for Gene Synthesis, by Method, Through 2031
• Table 26 : European Market for Gene Synthesis, by Services, Through 2031
• Table 27 : European Market for Gene Synthesis, by Application, Through 2031
• Table 28 : European Market for Gene Synthesis, by End User, Through 2031
• Table 29 : European Market for Gene Synthesis, by Country, Through 2031
• Table 30 : Asia-Pacific Market for Gene Synthesis, by Method, Through 2031
• Table 31 : Asia-Pacific Market for Gene Synthesis, by Services, Through 2031
• Table 32 : Asia-Pacific Market for Gene Synthesis, by Application, Through 2031
• Table 33 : Asia-Pacific Market for Gene Synthesis, by End User, Through 2031
• Table 34 : Asia-Pacific Market for Gene Synthesis, by Country, Through 2031
• Table 35 : Rest of the World Market for Gene Synthesis, by Method, Through 2031
• Table 36 : Rest of the World Market for Gene Synthesis, by Services, Through 2031
• Table 37 : Rest of the World Market for Gene Synthesis, by Application, Through 2031
• Table 38 : Rest of the World Market for Gene Synthesis, by End User, Through 2031
• Table 39 : Rest of the World Market for Gene Synthesis, by Sub-Region, Through 2031
• Table 40 : Ranking of Leading Companies in Gene Synthesis Market, 2025
• Table 41 : Agreements, Collaborations and Partnerships in the Gene Synthesis Market, 2025-2026
• Table 42 : Product Launches in the Gene Synthesis Market, 2024-2026
• Table 43 : Other Strategic Developments in the Gene Synthesis Market 2024-2026
• Table 44 : Abbreviations Used in this Report
• Table 45 : Ansa Biotechnologies: Company Snapshot
• Table 46 : Ansa Biotechnologies: Product Portfolio
• Table 47 : Ansa Biotechnologies: News/Key Developments, 2024-2026
• Table 48 : Azenta US Inc.: Company Snapshot
• Table 49 : Azenta US Inc.: Financial Performance, FY 2024 and 2025
• Table 50 : Azenta US Inc.: Product Portfolio
• Table 51 : Azenta US Inc.: News/Key Developments, 2026
• Table 52 : Creative Biogene: Company Snapshot
• Table 53 : Creative Biogene: Product Portfolio
• Table 54 : DNA TwoPointO Inc.: Company Snapshot
• Table 55 : DNA TwoPointO Inc.: Product Portfolio
• Table 56 : DNA TwoPointO Inc.: News/Key Developments, 2026
• Table 57 : Eurofins Genomics: Company Snapshot
• Table 58 : Eurofins Genomics: Product Portfolio
• Table 59 : Eurofins Genomics: News/Key Developments, 2025
• Table 60 : Evonetix: Company Snapshot
• Table 61 : Evonetix: Product Portfolio
• Table 62 : GenScript: Company Snapshot
• Table 63 : GenScript: Financial Performance, FY 2024 and 2025
• Table 64 : GenScript: Product Portfolio
• Table 65 : GenScript: News/Key Developments, 2024
• Table 66 : Integrated DNA Technologies Inc.: Company Snapshot
• Table 67 : Integrated DNA Technologies Inc.: Product Portfolio
• Table 68 : Integrated DNA Technologies Inc.: News/Key Developments, 2024-2026
• Table 69 : Merck KGaA: Company Snapshot
• Table 70 : Merck KGaA: Financial Performance, FY 2024 and 2025
• Table 71 : Merck KGaA: Product Portfolio
• Table 72 : Merck KGaA: News/Key Developments, 2026
• Table 73 : OriGene Technologies Inc.: Company Snapshot
• Table 74 : OriGene Technologies Inc.: Product Portfolio
• Table 75 : ProMab: Company Snapshot
• Table 76 : ProMab: Product Portfolio
• Table 77 : Synbio Technologies Inc.: Company Snapshot
• Table 78 : Synbio Technologies Inc.: Product Portfolio
• Table 79 : Synbio Technologies Inc.: News/Key Developments, 2026
• Table 80 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 81 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
• Table 82 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 83 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025-2026
• Table 84 : trenzyme GmbH: Company Snapshot
• Table 85 : trenzyme GmbH: Product Portfolio
• Table 86 : Twist Bioscience: Company Snapshot
• Table 87 : Twist Bioscience: Financial Performance, FY 2024 and 2025
• Table 88 : Twist Bioscience: Product Portfolio
• Table 89 : Twist Bioscience: News/Key Developments, 2026

List of Figures

• Summary Figure : Summary Figure: Global Market Shares of Gene Synthesis, by Region, 2025
• Figure 1 : Gene Synthesis Services Workflow
• Figure 2 : PESTEL Analysis: Gene Synthesis Market
• Figure 3 : Market Dynamics of Gene Synthesis Technologies
• Figure 4 : Emerging Technologies in the Gene Synthesis Market
• Figure 5 : Patent Filings Related to Gene Synthesis, by Year, 2024-2025
• Figure 6 : Shares of Patents, by Document Type, 2024-2025
• Figure 7 : Global Market Shares of Gene Synthesis, by Method, 2025
• Figure 8 : Global Market Shares of Gene Synthesis, by Services, 2025
• Figure 9 : Global Market Shares of Gene Synthesis, by Application, 2025
• Figure 10 : Global Market Shares of Gene Synthesis, by End User, 2025
• Figure 11 : Global Market Shares of Gene Synthesis, by Region, 2025
• Figure 12 : North American Market Shares of Gene Synthesis, by Country, 2025
• Figure 13 : European Market Shares of Gene Synthesis, by Country, 2025
• Figure 14 : Asia-Pacific Market Shares of Gene Synthesis, by Country, 2025
• Figure 15 : Rest of the World Market Shares of Gene Synthesis, by Sub-Region, 2025
• Figure 16 : Azenta US Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 17 : Azenta US Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 18 : GenScript: Revenue Shares, by Business Unit, FY 2025
• Figure 19 : GenScript: Revenue Shares, by Country/Region, FY 2025
• Figure 20 : Merck KGaA: Revenue Shares, by Business Unit, FY 2025
• Figure 21 : Merck KGaA: Revenue Shares, by Country/Region, FY 2025
• Figure 22 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 23 : Thermo Fisher Scientific Inc.: Revenue Shares, Country/by Region, FY 2025
• Figure 24 : Twist Bioscience: Revenue Shares, by Business Unit, FY 2025
• Figure 25 : Twist Bioscience: Revenue Shares, Country/by Region, FY 2025